EUVIMEDEUVIMED entdecken
Crossref

Meclozine and growth hormone ameliorate bone length and quality in experimental models of achondroplasia

Kenta Sawamura, Masaki Matsushita, Ryusaku Esaki, Kenichi Mishima, Yasunari Kamiya, Kinji Ohno, Hiroshi Kitoh, Shiro Imagama

Journal of Bone and Mineral Metabolism · 2025

DOI: 10.1007/s00774-024-01563-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bone and Mineral Metabolism, 2025. Verfasst von Kenta Sawamura und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, 466-8550, Japan. Hauptthemen laut MEDLINE: Achondroplasia, Growth Hormone, Bone and Bones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AchondroplasiaGrowth HormoneBone and BonesAnimalsDisease Models, AnimalMiceBone DensityMice, TransgenicBone DevelopmentMaleX-Ray Microtomography

Stichwörter der Autor:innen

AchondroplasiaBone growthFibroblast growth factor receptor 3Growth hormoneMeclozine

Substanzen

Growth Hormone

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, 466-8550, Japan.
  • Division of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Aichi, 466-8550, Japan.
  • Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, Nagoya, Aichi, 466-8550, Japan. matsushita.masaki.a7@f.mail.nagoya-u.ac.jp.
  • Graduate School of Nutritional Sciences, Nagoya University of Arts and Sciences, Nisshin, Aichi, 470-0196, Japan.
  • Department of Orthopaedic Surgery, Aichi Children's Health and Medical Center, Obu, Aichi, 474-8017, Japan.
  • Department of Comprehensive Pediatric Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, 466-8550, Japan.

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Society for the Promotion of Science
  • Takeda Science Foundation

Zitieren

APA

Sawamura, K., Matsushita, M., Esaki, R., Mishima, K., Kamiya, Y., Ohno, K., Kitoh, H., & Imagama, S. (2025). Meclozine and growth hormone ameliorate bone length and quality in experimental models of achondroplasia. Journal of Bone and Mineral Metabolism. https://doi.org/10.1007/s00774-024-01563-x

Vancouver

Sawamura K, Matsushita M, Esaki R, Mishima K, Kamiya Y, Ohno K, et al. Meclozine and growth hormone ameliorate bone length and quality in experimental models of achondroplasia. Journal of Bone and Mineral Metabolism. 2025. doi:10.1007/s00774-024-01563-x

BibTeX
@article{Sawamura2025,
  author = {Sawamura, Kenta and Matsushita, Masaki and Esaki, Ryusaku and Mishima, Kenichi and Kamiya, Yasunari and Ohno, Kinji and Kitoh, Hiroshi and Imagama, Shiro},
  title = {Meclozine and growth hormone ameliorate bone length and quality in experimental models of achondroplasia},
  journal = {Journal of Bone and Mineral Metabolism},
  year = {2025},
  doi = {10.1007/s00774-024-01563-x}
}
Kostenlos starten →